SUNNY RAICHART: Open Payments
NPI 1720687106 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 56 payments from 15 companies in 2025. Trend: 2023 $676 · 2024 $1,211 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| Corcept Therapeutics | 9 | $184 |
| Amgen Inc. | 3 | $143 |
| Vanda Pharmaceuticals Inc. | 6 | $136 |
| Novo Nordisk Inc | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| Lilly USA, LLC | 1 | $28 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $21 |
Products named: Korlym, QULIPTA, FANAPT, REPATHA, VRAYLAR, CAPLYTA, Ozempic, VOQUEZNA.
Industry payments across ID — which companies pay providers there.
